Why Revvity (RVTY) Stock Is Up Today

Revvity (RVTY) is up 8.5% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver is investor enthusiasm around Revvity’s newly announced Human Cell Design acquisition, which expands the company’s tools for metabolic disease research and ties into active interest in GLP-1-related drug discovery. The move may also be getting support from the company’s recently improved full-year outlook and still-favorable sentiment after stronger second-quarter results, although there does not appear to be a single fresh filing today that fully explains the jump.

Details:

On September 9, Revvity announced a definitive agreement to acquire Human Cell Design, a France-based biotech focused on human cell models and preclinical research tools for diabetes, obesity, and other metabolic diseases.

The deal is expected to add human pancreatic beta cell models to Revvity’s Life Sciences portfolio and broaden its capabilities in screening, detection, high-content analysis, and gene editing for drug discovery workflows.

In its August 4 second-quarter update, Revvity said results came in above expectations, highlighted double-digit organic growth in Diagnostics, and raised full-year guidance to revenue of $2.83 billion to $2.86 billion and adjusted EPS of $5.30 to $5.40.

Recent analyst activity has also leaned constructive, with one September price-target increase to $140 helping reinforce the view that the company’s growth outlook has improved.

Sources:

Revvity Investor Relations, SEC, Benzinga

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$RVTY Insider Trading Activity

$RVTY insiders have traded $RVTY stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $RVTY stock by insiders over the last 6 months:

ANITA GONZALES (Vice President and CAO) has made 0 purchases and 2 sales selling 165 shares for an estimated $16,729.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$RVTY Hedge Fund Activity

We have seen 304 institutional investors add shares of $RVTY stock to their portfolio, and 259 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

PRICE T ROWE ASSOCIATES INC /MD/ removed 4,559,308 shares (-45.2%) from their portfolio in Q2 2026, for an estimated $507,268,608
VICTORY CAPITAL MANAGEMENT INC added 3,366,756 shares (+1206.1%) to their portfolio in Q2 2026, for an estimated $374,585,272
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 2,416,183 shares (+15.2%) to their portfolio in Q2 2026, for an estimated $268,824,520
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 1,085,608 shares (+inf%) to their portfolio in Q2 2026, for an estimated $120,784,746
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 1,065,520 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $118,549,755
WELLINGTON MANAGEMENT GROUP LLP added 857,526 shares (+10653.8%) to their portfolio in Q2 2026, for an estimated $95,408,342
PICTET ASSET MANAGEMENT HOLDING SA added 734,000 shares (+81.8%) to their portfolio in Q2 2026, for an estimated $81,664,840

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$RVTY Government Contracts

We have seen $3,746,173 of award payments to $RVTY over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

SERVICE/MAINTENANCE AGREEMENT OPERETTA CLS (1), OPERA PHENIX (6), FLEX 750 AND ROBOT FIXED CELL UNITS AT NCATS: $696,235
MAINTENANCE AND SERVICE AGREEMENT FOR PE EQUIPMENT: $253,138
PREVENTATIVE MAINTENANCE FOR OPERA PHENIX PLUS SYSTEM: $100,093
PERKIN-ELMER QUANTUM GX IN VIVO MICROCT SCANNER MAINTENANCE SUPPORT SERVICES. MAY 1, 2023 - APRIL 30, 2024.: $99,089

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

$RVTY Congressional Stock Trading

Members of Congress have traded $RVTY stock 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $RVTY stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 2 purchases worth up to $65,000 on 05/04, 05/01 and 0 sales.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$RVTY Price Targets

Multiple analysts have issued price targets for $RVTY recently. We have seen 8 analysts offer price targets for $RVTY in the last 6 months, with a median target of $110.0.

Here are some recent targets:

Vijay Kumar from Evercore ISI Group set a target price of $125.0 on 07/06/2026
Eve Burstein from Bernstein set a target price of $115.0 on 06/26/2026
Luke Sergott from Barclays set a target price of $105.0 on 05/07/2026
Daniel Arias from Stifel set a target price of $100.0 on 05/06/2026
Dan Brennan from TD Cowen set a target price of $120.0 on 05/06/2026
Casey Woodring from JP Morgan set a target price of $90.0 on 05/06/2026
Catherine Ramsey from Baird set a target price of $125.0 on 05/04/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.